Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway
R Liu, Y Lu, J Li, W Yao, J Wu, X Chen, L Huang… - Cell Death & …, 2024 - nature.com
Abstract Annexin A2 (ANXA2) is a widely reported oncogene. However, the mechanism of
ANXA2 in esophageal cancer is not fully understood. In this study, we provided evidence …
ANXA2 in esophageal cancer is not fully understood. In this study, we provided evidence …
Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma
Y Miao, M Dong, Q Zhou, J Thiel, N Li, Y Cai… - Frontiers in …, 2024 - frontiersin.org
Background Low-grade endometrial stromal sarcoma (LG-ESS) is a rare uterine malignancy
characterized by its complex tumor microenvironment (TME) and high recurrence rates …
characterized by its complex tumor microenvironment (TME) and high recurrence rates …
Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling
Y Lin, X Chen, L Lin, B Xu, X Zhu, X Lin - Cellular & Molecular Biology …, 2024 - Springer
Background Endometrial cancer (EC) is one of the most common gynecological cancers.
Herein, we aimed to define the role of specific myosin family members in EC because this …
Herein, we aimed to define the role of specific myosin family members in EC because this …
[HTML][HTML] Gene Co-Expression Network Analysis Associated with Endometrial Cancer Tumorigenesis and Survival Outcomes
AJ Clark, R Singh, RL Leonis, EA Stahlberg… - International Journal of …, 2024 - mdpi.com
Endometrial cancer (EC) presents a substantial health challenge, with increasing incidence
and mortality rates. Despite advances in diagnosis and treatment, understanding the …
and mortality rates. Despite advances in diagnosis and treatment, understanding the …
[HTML][HTML] Exosomes regulate doxorubicin resistance in breast cancer via miR-34a-5p/NOTCH1
N Chen, K Zhou, Z Miao, Y Chen, J Cui, S Su - Molecular and Cellular …, 2024 - Elsevier
Breast cancer (BRCA) is the most common cancer among women. Adriamycin (ADR), also
known as doxorubicin (Dox), is a commonly used chemotherapeutic agent for BRCA …
known as doxorubicin (Dox), is a commonly used chemotherapeutic agent for BRCA …
Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer
Background: Endometrial cancer (EC) is recognized as the second most common type of
cancer among women. Interleukin-37 (IL-37) is a recently discovered member of the IL-1 …
cancer among women. Interleukin-37 (IL-37) is a recently discovered member of the IL-1 …
Altered threonine tyrosine kinase (TTK) expression is associated with adverse clinical outcomes in breast tumors: An in silico approach
GBR da Silva, BS Cruz, JG Vieira, JM Uzum… - Research, Society and …, 2023 - rsdjournal.org
The most common and lethal malignancy in women on a global scale remains breast
cancer. Threonine tyrosine kinase (TTK) has been shown to be a critical mitotic spindle …
cancer. Threonine tyrosine kinase (TTK) has been shown to be a critical mitotic spindle …
An exploration of newly found risk factors, diagnostic tools, and potential treatments for endometrial cancer
K Horner - Microreviews in Cell and Molecular …, 2023 - undergradsciencejournals.okstate …
Endometrial cancer is the fourth most common malignant tumor in women in the USA, with
cases continuing to rise each year. Several causes diagnostic tools, and potential treatments …
cases continuing to rise each year. Several causes diagnostic tools, and potential treatments …